Cover Page
The handle http://hdl.handle.net/1887/59755 holds various files of this Leiden University dissertation.
Author: Wilde, S.P. de
Title: Translation of academic medicinal products towards clinical practice
Issue Date: 2018-01-24
Part IV – LIST OF PUBLICATIONS, CURRICULUM VITAE
Part IV – LIST OF PUBLICATIONS, CURRICULUM VITAE
CHAPTER 12 List of Publications Curriculum vitae auctoris
CHAPTER 12 List of Publications Curriculum vitae auctoris
List of publications This thesis
de Wilde S, Veltrop-Duits L, Hoozemans-Strik M, Ras T, Blom-Veenman J, Guchelaar HJ, Zandvliet M, Meij P. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation. Cytotherapy 2016;18(6):797-805
de Wilde S, Guchelaar HJ, Herberts C, Lowdell M, Hildebrandt M, Zandvliet M, Meij P. Development of cell therapy medicinal products by academic institutes. Drug Discovery Today 2016;21(8):1206-12
de Wilde S, Guchelaar HJ, Zandvliet ML, Meij P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol Ther Methods Clin Dev. 2016;3:16073
de Wilde S, Guchelaar HJ, Zandvliet ML, Meij P. Understanding clinical development of chimeric antigen receptor T cell therapies. Cytotherapy 2017;19(6):703-709
de Wilde S, de Jong M, Le Brun P, Guchelaar HJ, Schimmel K. Unlicensed pharmaceutical preparations for clinical patient care: ensuring safety. Pharmacoepidemiology and Drug Safety. 2017 October 19,
de Wilde S, de Jong M, Lipka A, Guchelaar HJ, Schimmel K. The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome. European Journal of Pharmaceutical Sciences. 2017 November 27.
de Wilde S*, Coppens D*, Hoekman J, de Bruin M, Leufkens H, Guchelaar HJ, Meij P. Decision-making on marketing authorization of advanced therapy medicinal products in the European Union.
Submitted
* These authors contributed equally to this work
Not related to this thesis
Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.
Psychopharmacology 2013;229(1):199-208
List of publications - Part IV |189
12
List of publications This thesis
de Wilde S, Veltrop-Duits L, Hoozemans-Strik M, Ras T, Blom-Veenman J, Guchelaar HJ, Zandvliet M, Meij P. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation. Cytotherapy 2016;18(6):797-805
de Wilde S, Guchelaar HJ, Herberts C, Lowdell M, Hildebrandt M, Zandvliet M, Meij P. Development of cell therapy medicinal products by academic institutes. Drug Discovery Today 2016;21(8):1206-12
de Wilde S, Guchelaar HJ, Zandvliet ML, Meij P. Clinical development of gene- and cell-based therapies: overview of the European landscape. Mol Ther Methods Clin Dev. 2016;3:16073
de Wilde S, Guchelaar HJ, Zandvliet ML, Meij P. Understanding clinical development of chimeric antigen receptor T cell therapies. Cytotherapy 2017;19(6):703-709
de Wilde S, de Jong M, Le Brun P, Guchelaar HJ, Schimmel K. Unlicensed pharmaceutical preparations for clinical patient care: ensuring safety. Pharmacoepidemiology and Drug Safety. 2017 October 19,
de Wilde S, de Jong M, Lipka A, Guchelaar HJ, Schimmel K. The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome. European Journal of Pharmaceutical Sciences. 2017 November 27.
de Wilde S*, Coppens D*, Hoekman J, de Bruin M, Leufkens H, Guchelaar HJ, Meij P. Decision-making on marketing authorization of advanced therapy medicinal products in the European Union.
Submitted
* These authors contributed equally to this work
Not related to this thesis
Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.
Psychopharmacology 2013;229(1):199-208
Curriculum Vitae auctoris
Sofieke de Wilde was born in Kampen, The Netherlands, on 15 May 1988. After she finished secondary school at Gymnasium Celeanum in Zwolle, she started in 2006 with the bachelor Pharmacy at the University of Groningen. After her Bachelor of Science, she continued with the Master Pharmacy at the University of Utrecht. During her Master studies, she performed a research internship on the influence of oxytocin on fear extinction in humans at the Mark Geyer lab at the University of California, San Diego (department of Psychiatry under supervision of V.B. Risbrough, Ph.D.). In 2013, Sofieke obtained her Master’s Degree in Pharmacy and started working as a project pharmacist at the department Clinical Pharmacology and Pharmacy at the VU Medical Center in Amsterdam (supervisors P.M. Bet, Ph.D and M.W.J. den Brok, Ph.D.). One year later, she transferred to the department Clinical Pharmacy and Toxicology of the Leiden University Medical Center where she started her Ph.D. project on translation of academic medicinal products towards clinical practice (supervisor professor H-J. Guchelaar, Ph.D.). From July 2017 Sofieke worked as a project pharmacist at the hospital pharmacy of the Zaans Medical Center in Zaandam and in November 2017 she started her residency Hospital Pharmacy at the Meander Medical Center in Amersfoort. Sofieke lives in Amsterdam together with Merijn.
Curriculum Vitae auctoris - Part IV |191
12
Curriculum Vitae auctoris
Sofieke de Wilde was born in Kampen, The Netherlands, on 15 May 1988. After she finished secondary school at Gymnasium Celeanum in Zwolle, she started in 2006 with the bachelor Pharmacy at the University of Groningen. After her Bachelor of Science, she continued with the Master Pharmacy at the University of Utrecht. During her Master studies, she performed a research internship on the influence of oxytocin on fear extinction in humans at the Mark Geyer lab at the University of California, San Diego (department of Psychiatry under supervision of V.B. Risbrough, Ph.D.). In 2013, Sofieke obtained her Master’s Degree in Pharmacy and started working as a project pharmacist at the department Clinical Pharmacology and Pharmacy at the VU Medical Center in Amsterdam (supervisors P.M. Bet, Ph.D and M.W.J. den Brok, Ph.D.). One year later, she transferred to the department Clinical Pharmacy and Toxicology of the Leiden University Medical Center where she started her Ph.D. project on translation of academic medicinal products towards clinical practice (supervisor professor H-J. Guchelaar, Ph.D.). From July 2017 Sofieke worked as a project pharmacist at the hospital pharmacy of the Zaans Medical Center in Zaandam and in November 2017 she started her residency Hospital Pharmacy at the Meander Medical Center in Amersfoort. Sofieke lives in Amsterdam together with Merijn.
